Overview

Ozurdex for Retinal Vein Occlusion Study (ORVO Study)

Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
To measure the pro-permeability factors in the aqueous humor of patients with persistent/recurrent macular edema after an injection of Ozurdex.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Johns Hopkins University
Collaborator:
Allergan
Treatments:
BB 1101
Dexamethasone
Dexamethasone 21-phosphate
Dexamethasone acetate